| ○ |
| 上田 龍三 |
愛知医科大学医学部・教授 |
| 腫瘍内科学 |
Ishida T, Joh T, Uike N, Yamamoto K, Utsunomiya A, Yoshida S, Saburi Y, Miyamoto T, Takemoto S, Suzushima H, Tsukasaki K, Nosaka K, Fujiwara H, Ishitsuka K, Inagaki H, Ogura M, Akinaga S, Tomonaga M, Tobinai K, Ueda R. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study.
J Clin Oncol. 2012 Mar 10;30(8):837-42. （Epub 2012 Feb 6） |
Nishikawa H, Maeda Y, Ishida T, Gnjatic S, Sato E, Mori F, Sugiyama D, Ito A, Fukumori Y, Utsunomiya A, Inagaki H, Old LJ, Ueda R, Sakaguchi S. Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma
Blood. 2012 Mar 29;119(13):3097-104.(Epub 2012 Feb 8) |
Masaki A, Ishida T, Suzuki S, Ito A, Mori F, Sato F, Narita T, Yamada T, Ri M, Kusumoto S, Komatsu H, Tanaka Y, Niimi A, Inagaki H, Iida S, Ueda R. Autologous Tax-Specific CTL Therapy in a Primary Adult T Cell Leukemia/Lymphoma Cell-Bearing NOD/Shi-scid, IL-2Rγnull Mouse Model
J Immunol. 2013 Jul 1;191(1):135-44. （Epub 2013 Jun 3） |
|
| |
| 加藤 治文 |
東京医科大学名誉教授
新座志木中央総合病院名誉院長
国際医療福祉大学大学院教授 |
| 胸部外科、呼吸器外科 |
| A Randomized Trial of Adjuvant Chemotherapy with Uracil-Tegafur for Adenocarcinoma of the Lung. Kato H, Ichinose Y, Ohta M, et al. N Engl J Med USA, 2004 April 350: 1713-1721 |
| Development for a growing Japanese patient population: Facilitating new technologies for future health care. Kato H, Nishimura T, Ikeda N, et al. J Proteomics Netherlands, 201 74:759-764 |
「臨床プロテオミクス−バイオマーカー探索から個別化医療へ」編集：日本プロテオーム研究会 編集代表：中村和行、西尾和人、西村俊秀 監修：加藤治文
金原出版 （2012） |
|
| |
| 澁谷 正史 |
上武大学副学長、東京大学名誉教授 |
| 分子生物学、血管生物学 |
| Nucleotide Sequence of Fujinami Sarcoma Virus : Evolutionary Relationship of its Transforming Gene with Transforming Genes of Other Sarcoma Viruses. Shibuya M, Hanafusa H. Cell, 30, 787-795, 1982. |
| A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-γ and DNA synthesis in vascular endothelial cells. Takahashi T, Yamaguchi S, Chida K, Shibuya M. EMBO J. 20, 2768-2778, 2001. |
| Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Shibuya M, Claesson-Welsh L. Exp Cell Res. 312, 549-560, 2006.（総説、査読なし. 2006-2011に本誌としてトップクラスで引用され、表彰された。） |
|
| |
| 新海 哲 |
独立行政法人国立病院機構四国がんセンター院長 |
| 臨床腫瘍学 |
| Serial plasma carcinoembryonic antigen measurement for monitoring patients with advanced lung cancer during chemotherapy. Shinkai T, Saijo N, Tominaga K, Eguchi K, Shimizu E, Sasaki Y, Fujita F, Futami H, Ohkura O. Suemasu K. Cancer 1986 57:1318-1323. |
| Cytogenetic effect of carboplatin on human lymphocytes. Shinkai T, Saijo N, Eguchi K, Sasaki Y, Tamura T, Sakurai M, Suga J, Nakano H, Nakagawa K, Hong WS, Nakajima T. Cancer Chemother Pharmacol 1988 21:203-207. |
| Phase I clinical trial of irinotecan (CPT-11), 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, and cisplatin in combination with fixed dose of vindesine in advanced non-small cell lung cancer. Shinkai T, Arioka H, Kunikane H, Eguchi K, Sasaki Y, Tamura T, Ohe Y, Oshita F, Nishio M, Karato A, Okamoto H, Nakashima H, Ohmatsu H, Shiraishi J, Nomura N. and Saijo N. Cancer Res 1994 54:2636-2642. |
|
| |
| 田島 和雄 |
愛知県がんセンター研究所 |
| 疫学、予防医学 |
がん予防の最前線、上巻「基礎知識から新戦略へ」、下巻「最新の研究成果と予防戦略」、田島和雄監修、著者（各巻各1編）
昭和堂（上巻：2004、下巻：2005） |
脂肪酸測定のための方法およびシステム
番号：4359661、田島和雄、栗木清典
2009年8月21日取得 |
| Ethnoepidemiology of Asian cancer epidemic pattern and its prevention strategy (Plenary Lecture), Kazuo Tajima, Asian Pacific Cancer Conference, 2011 |
|
| |
| 中釜 斉 |
独立行政法人国立がん研究センター
理事（兼）研究所長 |
| 分子腫瘍学、翻訳制御機構の異常と消化器発がん、環境発がん、比較ゲノミクス |
| Okamoto K, Ishiguro T, Midorikawa Y, Ohata H, Izumiya M, Tsuchiya T, Sato A, Sakai H, and Nakagama H. miR-493 induction during carcinogenesis blocks metastatic settlement of colon cancer cells in liver. EMBO J, 31(7):1752-63, 2012 |
| Tsuchiya N, Izumiya M, Ogata-Kawata H, Okamoto K, Fujiwara Y, Nakai M, Okabe A, Schetter AJ, Bowman ED, Midorikawa Y, Sugiyama Y, Aburatani H, Harris CC, Nakagama H. Tumor Suppressor miR-22 Determines p53-Dependent Cellular Fate through Post-transcriptional Regulation of p21. Cancer Res, 71(13):4628-4639, 2011 |
| Tazawa H, Tsuchiya N, Izumiya M and Nakagama H. Tumor suppressive miR-34a induces senescence-like growth arrest through modulation of E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA, 104:15472-15477, 2007. |
|
| |
| 前原 喜彦 |
九州大学大学院 消化器・総合外科 教授 |
| 消化器（消化管、肝・胆・膵、脾・門脈）移植 肺 乳腺 血管 |
Colorectal cancer screening with odour material by canine scent detection.
Sonoda H, Kohnoe S, Yamazato T, Satoh Y, Morizono G, Shikata K, Morita M, Watanabe A, Morita M, Kakeji Y, Inoue F, Maehara Y. GUT 60(6):814-819, 2011 |
Copy-neutral loss of heterozygosity at the p53 locus in carcinogenesis of esophageal squamous cell carcinomas associated with p53 mutations.
Saeki H, Kitao H, Yoshinaga K, Nakanoko T, Kubo N, Kakeji Y, Morita M, Maehara Y. Clin Cancer Res 17(7):1731-1740, 2011 |
Diacylglycerol kinase alpha enhances hepatocellular carcinoma progression by activation of Ras-Raf-MEK-ERK pathway.
Takeishi K, Taketomi A, Shirabe K, Toshima T, Motomura T, Ikegami T, Yoshizumi T, Sakane F, Maehara Y. J Hepatol 57(1):77-83, 2012 |
|
| |
|
